The Cannabis Mental Health Evidence Gap: Association vs. Causation
The cannabis mental health evidence gap highlights the challenges in distinguishing association from causation in cognitive decline studies. Current research shows no clear link between cannabis use and dementia risk in older adults. Clinicians must…
Research on Cannabis Compounds and Metabolic Dysfunction in Adults
This article explores cannabis compounds metabolic dysfunction and their potential impact on reversing disease affecting one-third of adults. The research highlights emerging findings on cannabis compounds as a possible intervention for metabolic health.…
Cannabis compounds could reverse disease affecting one-third of adults – New York Post
Recent studies highlight non-psychoactive cannabis compounds metabolic disease potential, especially for conditions like metabolic syndrome. These compounds offer therapeutic promise without psychoactive effects. However, clinical validation is needed…
New Study Shows Cannabinoids Reduce Liver Fat Accumulation
Emerging evidence suggests cannabinoids reduce hepatic steatosis, potentially benefiting fatty liver disease. CBD and CBG show promise in preclinical models. Clinical trials are needed to confirm these findings.
Colorado Scientists Discover Cannabis Benefits for Memory and Brain Size in Older People
Emerging research on cannabis brain volume older adults suggests potential benefits for memory and cognitive function. A large study found larger brain volumes in cannabis users aged 40 and older. These findings highlight the need for further research on…
The Florida Cannabis Debate Will Still Be Around
The florida cannabis regulation impact is significant for older adults self-treating with cannabis for pain and sleep. Despite ongoing policy debates, this trend continues to grow. Clinicians need evidence-based guidance to counsel this population…
Medical Cannabis Can Play Key Role in UK Mental Health Crisis
Emerging evidence highlights medical cannabis mental health UK applications as promising adjunctive treatments for treatment-resistant psychiatric conditions. This article reviews clinical data relevant to the UK mental health crisis. Medical cannabis…
How Cannabis is Reshaping the Menopause Conversation | GreenState
Cannabis efficacy for menopause symptoms is gaining clinical interest as patients seek alternatives for hot flashes, mood changes, and sleep disruption. The endocannabinoid system’s role in regulating these symptoms offers a biological rationale for…
Emerging Role of Cannabis Compounds in Fatty Liver Disease
Emerging research shows cannabis compounds metabolic pathways may modulate metabolic-associated fatty liver disease (MASLD). This condition affects millions with limited treatment options. Understanding these pathways is crucial for clinicians monitoring…
Daily Digest: Last 2 Hours: Stroke Risk, Industry Maturation, and Reassurance for Older Adults — March 09, 2026
A synthesis of 9 recently added cannabis articles — key themes, clinical context, and Dr. Caplan's take.